RTI uses cookies to offer you the best experience online. By and clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.


Rx Summit 2020 Quiz: Treatment

The Data Story

Increasing access to substance use disorder (SUD) treatment is critical but establishing quality treatment for SUD and opioid use disorder is the only way to ensure treatment efforts are successful and enduring.

RTI is supporting treatment efforts by

  • Helping to establish a “learning health care system” in which patient outcomes data are collected and used to facilitate quality improvement
  • Identifying and monitoring barriers to accessing care and where they have been removed, including through Medicare and other policies
  • Working with nonprofits and states to develop additional quality measurement systems and help people find and connect with quality treatment services.


Return to the Rx Summit Quiz Page

Question 1 of 6

Of the 21.2 million people who needed substance use treatment in 2018, what percentage received treatment?

Question 2 of 6

According to the 2018 National Survey on Drug Use and Health, what percentage of people who felt that they needed substance use treatment said they did not receive treatment at a special facility because they did not know where to go to receive treatment?

Question 3 of 6

According to the Substance Abuse and Mental Health Services Administration, as of October 2019, approximately how many substance abuse treatment locations are there in the United States?

Question 4 of 6

What percentage of the 9.2 million adults with co-occurring mental illness and substance use disorder (SUD) received both mental health services and specialty substance abuse treatment in 2018?

Question 5 of 6

According to an RTI study, what percentage of patients who were admitted to the hospital for an opioid use disorder (OUD) or opioid overdose engaged in SUD treatment within 30 days after being discharged?

Question 6 of 6

In 2017, 88% of Medicare Part D plans required prior authorization for brand-name buprenorphine-naloxone—the most commonly prescribed medication to treat OUD.

What percentage of plans required prior authorization in 2019?